Role of tissue transglutaminase-2 (TG2)-mediated aminylation in biological processes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Amino Acids

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00726-016-2270-8PMID 27270573
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models

  2016cited by this paper
• Uncovering protein polyamination by the spermine-specific antiserum and mass spectrometric analysis

  2015cited by this paper
• Serotonylation and Transamidation of Other Monoamines.

  2015influential reference
• Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters

  2015cited by this paper
• Beyond Gene Inactivation: Evolution of Tools for Analysis of Serotonergic Circuitry.

  2015cited by this paper
• Writing and Reading the Tubulin Code*

  2015cited by this paper
• Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

  2014cited by this paper
• Transglutaminase regulation of cell function.

  2014influential reference
• Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules.

  2013influential reference
• TGM2 and implications for human disease: role of alternative splicing.

  2013cited by this paper
• Histaminylation of fibrinogen by tissue transglutaminase-2 (TGM-2): potential role in modulating inflammation

  2013cited by this paper
• Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E

  2013cited by this paper
• Microtubule stability in the axon: new answers to an old mystery.

  2013influential reference
• Characterization of Heparin-binding Site of Tissue Transglutaminase

  2012cited by this paper
• Histaminylation of glutamine residues is a novel posttranslational modification implicated in G-protein signaling

  2012influential reference
• Tissue Transglutaminase Constitutively Activates HIF-1α Promoter and Nuclear Factor-κB via a Non-Canonical Pathway

  2012cited by this paper
• Transglutaminase 2: a molecular Swiss army knife.

  2012influential reference
• Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

  2012influential reference
• Activation of Extracellular Transglutaminase 2 by Thioredoxin*

  2011cited by this paper
• Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes

  2011cited by this paper
• Extracellular TG2: emerging functions and regulation

  2011cited by this paper
• Beta-Actin is a Target for Transglutaminase Activity at Synaptic Endings in Chicken Telencephalic Cell Cultures

  2011cited by this paper
• γ-Glutamylamines and neurodegenerative diseases

  2011cited by this paper
• Spermidine Delays Eye Lens Opacification in vitro by Suppressing Transglutaminase-Catalyzed Crystallin Cross-Linking

  2011cited by this paper
• Novel roles for biogenic monoamines: from monoamines in transglutaminase‐mediated post‐translational protein modification to monoaminylation deregulation diseases

  2011influential reference
• Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease

  2010cited by this paper
• Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate.

  2010influential reference
• Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease

  2010cited by this paper
• Serotonin--more than a neurotransmitter: transglutaminase-mediated serotonylation of C6 glioma cells and fibronectin.

  2010cited by this paper
• Redox Regulation of Transglutaminase 2 Activity*

  2010influential reference
• Effects of post-translational modifications catalysed by pollen transglutaminase on the functional properties of microtubules and actin filaments.

  2009cited by this paper
• Transglutaminase activation in neurodegenerative diseases.

  2009influential reference
• Serotonylation of Vascular Proteins Important to Contraction

  2009cited by this paper
• Angiotensin II AT2 Receptor Oligomers Mediate G-protein Dysfunction in an Animal Model of Alzheimer Disease*

  2009cited by this paper
• Heparan Sulfate Proteoglycans Are Receptors for the Cell-surface Trafficking and Biological Activity of Transglutaminase-2

  2009cited by this paper
• Abstract 1708: Decreased S-Nitrosylation of Tissue Transglutaminase Contributes to Age-Related Increases in Vascular Stiffness

  2008cited by this paper
• Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination.

  2008cited by this paper
• Increased levels of γ‐glutamylamines in Huntington disease CSF

  2008cited by this paper
• Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.

  2008influential reference
• Tissue transglutaminase and the stress response

  2007cited by this paper
• A Role for Tissue Transglutaminase in Stabilization of Membrane-Cytoskeletal Particles Shed from the Human Placenta

  2007cited by this paper
• Transglutaminase 2 Undergoes a Large Conformational Change upon Activation

  2007cited by this paper
• Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: a new therapeutic opportunity.

  2007cited by this paper
• Coated‐platelet levels are influenced by smoking, aspirin, and selective serotonin reuptake inhibitors

  2007cited by this paper
• Identification of two GTP‐independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells

  2007cited by this paper
• Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

  2006cited by this paper
• Transglutaminase 2 in inflammation.

  2006influential reference
• GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.

  2006cited by this paper
• Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway.

  2006influential reference
• Tissue Transglutaminase-Mediated Formation and Cleavage of Histamine-Gliadin Complexes: Biological Effects and Implications for Celiac Disease1

  2005influential reference
• Mechanism for the inhibition of transglutaminase 2 by cystamine.

  2005cited by this paper
• Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking.

  2005cited by this paper
• Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions.

  2005cited by this paper
• Identification of a Novel Recognition Sequence for Fibronectin within the NH2-terminal β-Sandwich Domain of Tissue Transglutaminase*

  2005influential reference
• Site‐specific transamidation and deamidation of the small heat‐shock protein Hsp20 by tissue transglutaminase

  2005cited by this paper
• Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate‐independent mechanisms

  2005cited by this paper
• Paradoxical Inhibition of Protein Aggregation and Precipitation by Transglutaminase-catalyzed Intermolecular Cross-linking*

  2005cited by this paper
• Disrupted Spermine Homeostasis: A Novel Mechanism in Polyglutamine-Mediated Aggregation and Cell Death

  2004cited by this paper
• Treatment of neurodegenerative diseases with GPR49

  2004cited by this paper
• Cell-based assay for monitoring transglutaminase activity.

  2004cited by this paper
• Neurodegenerative disease: Neuron protection agency

  2004cited by this paper
• Transglutaminase 2 induces NF-κB activation via a novel pathway in BV-2 microglia

  2004influential reference
• Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

  2004cited by this paper
• Cell Type-specific Activation of Intracellular Transglutaminase 2 by Oxidative Stress or Ultraviolet Irradiation

  2004cited by this paper
• Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles.

  2004cited by this paper
• Histamine H1-receptor of vascular endothelial cells cultured from guinea pig skin

  2004cited by this paper
• Cross‐linking of ubiquitin, HSP27, parkin and α‐synuclein by γ‐glutamyl‐ε‐lysine bonds in Alzheimer's neurofibrillary tangles

  2004cited by this paper
• Tissue transglutaminase catalyzes the formation of alpha‐synuclein crosslinks in Parkinson's disease

  2004influential reference
• Tissue Transglutaminase Has Intrinsic Kinase Activity

  2004cited by this paper
• Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats

  2004cited by this paper
• Role of macrophage-derived histamine in atherosclerosis-- chronic participation in the inflammatory response --.

  2004cited by this paper
• Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase.

  2003cited by this paper
• Transglutaminases: crosslinking enzymes with pleiotropic functions

  2003influential reference
• Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform

  2003influential reference
• Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release.

  2003influential reference
• Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies

  2003cited by this paper
• Tissue Transglutaminase Mediates Activation of RhoA and MAP Kinase Pathways during Retinoic Acid-induced Neuronal Differentiation of SH-SY5Y Cells*

  2003cited by this paper
• A novel function of tissue-type transglutaminase: protein disulphide isomerase.

  2003cited by this paper
• Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine

  2003cited by this paper
• Differential incorporation of biotinylated polyamines by transglutaminase 2

  2003cited by this paper
• ‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease

  2002influential reference
• Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease

  2002cited by this paper
• Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases?

  2002cited by this paper
• Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques

  2002influential reference
• Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine

  2002cited by this paper
• Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity

  2002influential reference
• Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface

  2002influential reference
• Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

  2002cited by this paper
• Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets.

  2002influential reference
• Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine

  2002cited by this paper
• Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H2 receptors

  2001cited by this paper
• Localization of Tissue Transglutaminase in Human Carotid and Coronary Artery Atherosclerosis: Implications for Plaque Stability and Progression

  2001cited by this paper
• Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin.

  2001cited by this paper
• Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase.

  2001cited by this paper
• Role of transglutaminase II in retinoic acid‐induced activation of RhoA‐associated kinase‐2

  2001cited by this paper
• N(epsilon)-(gamma-L-glutamyl)-L-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease.

  2001cited by this paper
• Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition.

  2001cited by this paper
• Purification and substrate specificity of transglutaminases from blood and Streptoverticillium mobaraense.

  2001cited by this paper
• N ε ‐(γ‐l‐Glutamyl)‐l‐lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease

  2001cited by this paper
• Lysine-Rich Histone (H1) Is a Lysyl Substrate of Tissue Transglutaminase: Possible Involvement of Transglutaminase in the Formation of Nuclear Aggregates in (CAG)n/Qn Expansion Diseases

  2000cited by this paper

• Transglutaminase 2 activation is involved in thoracic aortic dissection through disruption of endothelial adherens junctions.

  2026cites this paper
• Monoaminylation in Human Health and Disease: State of the Field, Challenges, and Emerging Directions.

  2026cites this paper
• Novel PROTACs targeting tissue transglutaminase (TG2) suppress tumorigenicity of ovarian cancer cells.

  2025cites this paper
• From Discovery to Delivery: A Rapid and Targeted Proteomics Workflow for Monitoring Chinese Hamster Ovary Biomanufacturing

  2025cites this paper
• Counteracting TGM2 by a Fibroin peptide ameliorated Adriamycin-induced nephropathy via regulation of lipid metabolism through PANX1-PPAR α/PANK1 pathway.

  2024cites this paper
• Serotonin Influences Insulin Secretion in Rat Insulinoma INS-1E Cells

  2024cites this paper
• Smart responsive in situ hydrogel systems applied in bone tissue engineering

  2024cites this paper
• Transglutaminase2: An Enduring Enzyme in Diabetes and Age-Related Metabolic Diseases

  2024cites this paper
• S-Nitrosylation of Tissue Transglutaminase in Modulating Glycolysis, Oxidative Stress, and Inflammatory Responses in Normal and Indoxyl-Sulfate-Induced Endothelial Cells

  2023influential citation
• Proteomic profiling of epicardial fat in heart failure with preserved versus reduced and mildly reduced ejection fraction

  2023cites this paper
• GK921, a transglutaminase inhibitor, strengthens the antitumor effect of cisplatin on pancreatic cancer cells by inhibiting epithelial-to-mesenchymal transition.

  2023cites this paper
• Colon-targeted EMSCs conditional medium hydrogel for treatment of ulcerative colitis in mice

  2023cites this paper
• Empowering canonical biochemicals with cross‐linked novelty: Recursions in applications of protein cross‐links

  2023cites this paper
• EFFECTS OF CHLORBENZURON ON CUTICLE FORMATION OF HYPHANTRIA CUNEA (LEPIDOPTERA: EREBIDAE) AND ITS DETOXIFICATION METABOLISM

  2023cites this paper
• Identification and classification of papain-like cysteine proteinases

  2023cites this paper
• Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.

  2022cites this paper
• Organophosphates modulate tissue transglutaminase activity in differentiated C6 neural cells.

  2022cites this paper
• A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer

  2022cites this paper
• Ectoderm mesenchymal stem cells promote osteogenic differentiation of MC3T3-E1 cells by targeting sonic hedgehog signaling pathway

  2022cites this paper
• Untangling the Extracellular Matrix of Idiopathic Epiretinal Membrane: A Path Winding among Structure, Interactomics and Translational Medicine

  2022cites this paper
• Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy

  2022cites this paper
• Periodic Heat Stress Licenses EMSC Differentiation into Osteoblasts via YAP Signaling Pathway Activation

  2022cites this paper
• Recent advancements in enzyme-mediated crosslinkable hydrogels: In vivo-mimicking strategies

  2021cites this paper
• Histamine, Metabolic Remodelling and Angiogenesis: A Systems Level Approach

  2021cites this paper
• Propofol Suppresses Microglia Inflammation by Targeting TGM2/NF-κB Signaling

  2021cites this paper
• Periodic Heat Stress Licenses EMSCs Differentiation Into Osteoblasts via YAP Signaling Pathway Activation

  2021cites this paper
• Enhanced neural differentiation of neural stem cells by sustained release of Shh from TG2 gene-modified EMSC co-culture in vitro

  2020cites this paper
• Neurobiological Principles: Neurotransmitters

  2020cites this paper
• Solution-phase synthesis of the fluorogenic TGase 2 acyl donor Z-Glu(HMC)-Gly-OH and its use for inhibitor and amine substrate characterisation.

  2020cites this paper
• Transglutaminases: part I—origins, sources, and biotechnological characteristics

  2020cites this paper
• Increased Transglutaminase 2 Expression and Activity in Rodent Models of Obesity/Metabolic Syndrome and Aging

  2020cites this paper
• Transglutaminase-2 regulates Wnt and FoxO3a signaling to determine the severity of osteoarthritis

  2020cites this paper
• Polyamine Oxidase Is Involved in Spermidine Reduction of Transglutaminase Type 2-Catalyzed βH-Crystallins Polymerization in Calcium-Induced Experimental Cataract

  2020cites this paper
• Identification of Novel Inhibitors for TG2 (Tissue Transglutaminase) and DJ-1 (Protein Deglycase) against Parkinson's Diseases by Pharmacophore-based Approaches

  2020cites this paper
• In situ detection of intracellular tissue transglutaminase based on aggregation-induced emission.

  2020cites this paper
• Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease

  2020cites this paper
• HLA‐DQ genotype and biochemical characterization of anti‐transglutaminase 2 antibodies in patients with type 1 diabetes mellitus in Taiwan

  2020cites this paper
• Polyamines in mammalian pathophysiology

  2019cites this paper
• Proteomic analysis of the crustacean molting gland (Y-organ) over the course of the molt cycle.

  2019cites this paper
• Serotonylation: Serotonin Signaling and Epigenetics

  2019cites this paper
• Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells

  2018cites this paper
• Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects.

  2018cites this paper
• Docking Studies On Phytochemical Derivatives As Tissue Transglutaminase-2 (TG2) Inhibitors Aganist Lung Cancer

  2018cites this paper
• Alternative RNA splicing of leucocyte tissue transglutaminase in coeliac disease

  2018cites this paper
• Polyamine Homeostasis in Snyder-Robinson Syndrome

  2018cites this paper
• 1 Polyamine Homeostasis in Snyder-Robinson 2 Syndrome 3

  2018cites this paper
• Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease

  2018cites this paper
• Histone Post-Translational Modifications and Nucleosome Organisation in Transcriptional Regulation: Some Open Questions.

  2017cites this paper
• Transglutaminase 2, a double face enzyme

  2017cites this paper
• Endothelial cell-surface tissue transglutaminase inhibits neutrophil adhesion by binding and releasing nitric oxide

  2017cites this paper
• Protein Reviews

  2017cites this paper
• Tissue transglutaminase (TG2) and mitochondrial function and dysfunction.

  2017influential citation